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Abstract
Breast cancer screening imaging options have progressed greatly over the years in sensitivity,
specificity, and image quality. According to DynaMed Plus, in 2012 there were 522,000 deaths
by breast cancer and 1,677,000 total cases of breast cancer documented (Dynamed, 2018). For
years, traditional screening for breast cancer involved 2D digital mammography which obtains
two views of each breast. With advances in technology, the use of 3D breast tomosynthesis has
become an advantageous addition to routine breast cancer screening protocols at many health
care facilities.
My literature review of articles was found in PubMed, DynaMed Plus, Cochrane Library,
and Clinical Key from the year 2011 and on. These articles and resources focus on the current
recommendations for breast cancer screening. The benefits of 2D digital mammography alone,
3D breast tomosynthesis alone, and 2D digital mammography combined with 3D breast
tomosynthesis are compared. This study also compares the differences in radiation dose of each
imaging option. The research demonstrated that 2D digital mammography combined with 3D
breast tomosynthesis offers the lowest recall rates, the highest sensitivity and specificity, and
increases the effectiveness of breast cancer screening. The risk of this type of screening is the
potential increase in radiation dose depending on the type of imaging system and the minimal
increase in time the patient is under compression.

Key Terms: breast cancer screening, age 40 and older, 2D mammography, 3D
mammography, and radiation dose mammography.
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Benefits of 3D Breast Tomosynthesis Combined With 2D Digital Mammography in Screening
Women for Breast Cancer
When women reach the age of 40, they have the choice to start annual screening tests for
detection of breast cancer. By age 45, it becomes a recommendation that women start annual
screening for breast cancer. With advances in technology, screening for breast cancer can be
done in many ways. Two imaging options for screening are 2D digital mammography and 3D
breast tomosynthesis. Each healthcare facility develops its own protocol for breast cancer
screening. Some facilities have the resources to combine 2D digital mammography and 3D
breast tomosynthesis in one imaging system. 2D digital mammography has been considered the
gold standard for breast cancer screening (Dynamed, 2018).
2D digital mammography consists of two views of each breast under compression. 3D
breast tomosynthesis consists of the same views under compression for each breast. During 3D
breast tomosynthesis, the patient is under compression while the machine moves in a semicircular pattern to obtain many views from different angles. While the machine rotates around
the breast obtaining these different views, it is ultimately capable of imaging the breast tissue
with minimal superimposition. This is very helpful in patients who have dense breast tissue in
which cancer can easily hide. The digital ability of the 3D breast tomosynthesis machine
reconstructs the two views that are normally obtained by 2D digital mammography. There is
question as to whether the reconstructed views obtained by 3D breast tomosynthesis are
diagnostically comparable to those obtained by 2D digital mammography.
Most healthcare facilities who have access to the newest technology are changing their
breast screening protocols from 2D digital mammography to 3D breast tomosynthesis combined
with 2D digital mammography. In order to obtain the combination study, the patient undergoes
compression in which the first 2D image is taken followed by the 3D breast tomosynthesis
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images. These images are obtained under the same compression. Then the patient proceeds to
undergo the second round of compression to obtain the second view which completes the 2D
digital mammography series. The patient remains under compression while the machine rotates
and obtains the second 3D tomosynthesis view, thus completing the 3D breast tomosynthesis
series. When 2D digital mammography and 3D breast tomosynthesis are combined, the patient
does not undergo any additional views under compression. The additional time under
compression while obtaining the first 2D view and the 3D tomosynthesis view is minimal and
often does not cause any added discomfort to the patient.
Thanks to the advances in technology, providers and patients have increased access to
imaging modalities used for screening of breast cancer. These advances in technology allow
patients and providers access to breast imaging which increases sensitivity and specificity while
using a radiation dose as low as reasonably achievable. The purpose of this study is to compare
the specificity, sensitivity, and radiation dose of 2D digital mammography alone, 3D breast
tomosynthesis alone, and 2D digital mammography combined with 3D breast tomosynthesis.
This study involves screening in women age 40 and older for breast cancer. The sensitivity and
specificity of the imaging options weighs heavily on whether a patient is called back for further
imaging, studies, or procedures. When a patient receives the phone call that more imaging is
needed in addition to their annual screening, it causes a lot of anxiety and stress on the patient
and their family. Reducing the number of call backs for patients is beneficial to the patient, their
loved ones, and the institution in which the patient doctors.
Statement of the Problem
Each radiology imaging modality has its own risks and benefits, especially pertaining to
breast cancer screening. When a patient receives a 3D breast tomosynthesis scan, it can
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reconstruct images that a 2D digital mammography scan would provide. This could ultimately
eliminate the need for 2D digital mammography. Further investigation is needed to determine the
specificity, sensitivity, and radiation dose of 2D digital mammography, 3D breast tomosynthesis,
and these studies combined. This will help determine the safest and most effective imaging
protocol for screening of breast cancer as this is an annual recommendation.
Research Questions
In women age 40 and older, does screening for breast cancer using 3D breast
tomosynthesis alone versus 2D digital mammography alone offer increased accuracy, specificity,
sensitivity, and less call back tests for patients?
In women age 40 and older, does screening for breast cancer using combination of 2D
digital mammography with 3D breast tomosynthesis versus 2D digital mammography alone or
3D breast tomosynthesis alone offer increased accuracy, specificity, sensitivity, and less call
back tests for patients?
Methodology
For this review, four databases were searched including DynaMed Plus, Cochrane,
PubMed, and ClinicalKey from September 12, 2018 to September 30, 2018. The search method
used for four of the articles from PubMed include mesh term search details: (2d[All Fields] AND
("mammography"[MeSH Terms] OR "mammography"[All Fields]) AND versus[All Fields]
AND ("mammography"[MeSH Terms] OR "mammography"[All Fields] OR ("3d"[All Fields]
AND "mammography"[All Fields]) OR "3d mammography"[All Fields])) AND
("2008/09/26"[PDat] : "2018/09/23"[PDat]). Search terms utilized for ClinicalKey included the
following: breast cancer screening imaging, age 40 and older=-, full text, medline, systematic
reviews, randomized control trials, and meta-analyses. Search term utilized for Cochrane
database included: breast cancer screening imaging and tomosynthesis. The search terms, “breast
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cancer screening” was utilized in the DynaMed Plus database. Sources used and chosen for this
study are after the year 2011 and consist of randomized control trials, systematic reviews, and
meta analyses. Works that were excluded included those published prior to 2011, studies
performed on both men and women, and studies that included young women under the age of 18.
Review of the Literature
A review of literature has been conducted which provides evidence pertaining to the
benefits of using 3D breast tomosynthesis in conjunction with 2D digital mammography in
screening for breast cancer. The review demonstrates the increase in detection of suspicious
lesions and the decrease in number of patients who are called back for further work up. The
difference in radiation dosing between the two imaging options separately and combined is also
demonstrated.
The drawbacks to the studies include: relatively small participant groups, the variability
of patient’s breast tissue, not all studies had the ability to follow up on patients with breast cancer
providing sensitivity data, and different imaging systems were used from study to study.
Current screening recommendations and imaging options for breast cancer
It is considered a strong recommendation to start breast cancer screening for average-risk
women aged 50-74. Patients are offered screening at age 40 but this screening should be based
on shared decision making. Mammography is the imaging of choice for screening women with
average-risk of breast cancer. Screening of mammography is recommended every two years, but
annual screening should be discussed and considered with shared decision making. (Dynamed,
2018).
According to the American College of Radiology (ACR) Appropriateness Criteria for
Breast Cancer Screening, average-risk women age 40 and older should begin annual screening
mammography or 3D breast tomosynthesis (Mainiero et al., 2017). These guidelines are
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reviewed annually by a multidisciplinary expert panel. The screening age recommendation of 40
years was concluded based on review of randomized trials and subsequent meta-analyses. Based
on the articles and studies reviewed by the ACR, it was concluded that cancer detection rate
increased with 3D breast tomosynthesis compared to 2D digital mammography alone. It was also
found that recall rates for false-positive were decreased with the use of 3D breast tomosynthesis
(Mainiero et al., 2017).
Comparing 2D digital mammography alone and 3D breast tomososynthesis (with 2D
reconstruction) alone
Aase et al. (2018) published a randomized control study comparing 2D digital
mammography to 3D breast tomosynthesis. This study targeted about 14,089 women aged 50-69
years old. Each woman was randomly assigned to screening with either 2D digital
mammography or 3D breast tomosynthesis. The same imaging equipment was used on every
patient as well as the same reading workstation equipment and screens. In order to keep the study
consistent, each breast was assigned a score of 1-5 by the radiologist (1 being negative for
abnormality and 5 being high suspicion for malignancy). If the patient was assigned a score of 2
or higher on one or both breasts, this meant the radiologists gathered to determine whether the
patient needed to be called back for further imaging. This is often referred to as a recall. The
recall rate for 3D breast tomosynthesis was 3.0% and 3.6% for 2D digital mammography (p =
0.03) (Aase et al., 2018). The recall rate for women with dense breasts was 2.2% for 3D breast
tomosynthesis and 3.4% for 2D digital mammography (p = 0.04) (Aase et al., 2018). This
statistical information pertaining to women with dense breasts is significant. One of the benefits
of 3D breast tomosynthesis is that is eliminates superimposition. If a woman has dense breasts
her breast tissue displays as white on a mammogram, as does cancer. This means that cancer can
easily hide within dense breast tissue on a 2D digital mammogram. 3D breast tomosynthesis
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allows the radiologist and provider to essentially scan through the breast looking between the
dense breast tissue.
One factor to consider when comparing imaging modalities, is the amount of time the
patient spends under compression and in the exam room. This aspect was measured during this
study and it was found that the women who had 3D breast tomosynthesis spent an additional one
minute and five seconds in the exam room. According to the study, the time radiologists spent
reading and meeting for consensus was longer for 3D breast tomosynthesis than 2D digital
mammography. The average reading time was one minute and 11 seconds for 3D breast
tomosynthesis and 41 seconds for 2D digital mammography (p < 0.01) (Aase et al., 2018).
Mall et al. (2018) composed a study of 144 women aged 40 years and over in which 48
cases of cancers were randomly assigned to either 2D digital mammography or 3D breast
tomosynthesis for workup. Fifteen radiologists were recruited, and each radiologist read the 48
cases. The study compared the sensitivity, specificity, and positive (PPV) and negative predictive
value (NPV) (Mall et al., 2018). The radiologists’ performances were calculated using the
receiver-operating characteristics area under the curve (AUC). Radiologists had improved
performance (AUC = 0.927) with the use of 3D breast tomosynthesis when compared to 2D
digital mammography (AUC = 0.872). Similarly, the sensitivity, specificity, PPV, and NPV of
3D breast tomosynthesis (0.93, 0.75, 0.64, 0.96) were higher than 2D digital mammography
(0.90, 0.56, 0.49, 0.92). It was concluded that there was a significant reduction in the need for
additional views with 3D breast tomosynthesis (Mall et al., 2018).
The findings of the two trials coincide with results found in a meta-analysis performed by
Marinovich et al. (2018). The meta-analysis included 17 studies, 1,009,790 participants, from
433 citations and compared breast cancer screening detection and recall rate in asymptomatic
women for 3D breast tomosynthesis versus 2D digital mammography. In conclusion, 3D breast
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tomosynthesis improved cancer detection rates and reduced the recall rate (Marinovich et al.,
2018). The recall rate for 3D breast tomosynthesis was lower than 2D digital mammography
(pooled absolute reduction = -2.2%, 98% CI = -3.0 to -1.4, P < .001, I2 = 98.2%) (Marinovich et
al., 2018). The findings of this meta-analysis, again, demonstrates the benefits of 3D breast
tomosynthesis.
Comparing 2D digital mammography combined with 3D breast tomosynthesis
Twenty-one articles were analyzed in the systematic review constructed by Coop et al.
(2016). The review ultimately investigates whether 3D breast tomosynthesis should be used as a
screening tool, diagnostic tool, or both. It also considers whether 3D breast tomosynthesis could
potentially replaced 2D digital mammography or if it should be used alongside of it.
When 3D breast tomosynthesis is integrated with 2D digital mammography for screening,
it was found that results from various studies demonstrated a reduction in false-positive recalls
and positive predictive values raised. To state it simply, fewer women were recalled, and of those
who were recalled a greater percentage were found to have cancer. This again demonstrates that
cancer can easily hide behind tissue, especially dense breast tissue, and this superimposition of
breast tissue and cancer is one of the downfalls of 2D digital mammography. 3D breast
tomosynthesis reduces tissue superimposition making interpretation more accurate (Coop et al.,
2016).
The findings of Coop et al.’s (2016) systematic review was parallel with the findings of
another systematic review and a meta-analysis by Hodgson et al. (2016). Both reviews concluded
that when 2D digital mammography and 3D breast tomosynthesis are in conjunction with one
another, it results in the safest and most accurate screening protocol for breast cancer. Hodgson
et al.’s systematic review compared the two screening options; 3D with 2D digital
mammography versus 2D digital mammography alone. One study determined there was, “a

3D BREAST TOMOSYNTHESIS IN BREAST CANCER SCREENING

12

statistically significant higher invasive cancer detection rate in favor of 3D breast tomosynthesis
+ 2D digital mammography” (Hodgson et al., 2016 p.9). Results demonstrated more false
positives in 2D digital mammography groups with higher recall rates. The evidence from this
systematic review determined that 3D breast tomosynthesis combined with 2D digital
mammography increased invasive cancer detection rates and increased the effectiveness of breast
cancer screening.
A breast cancer research and treatment meta-analysis was completed by Yun et al.
(2017). This meta-analysis, again, paralleled the findings of Coop et al. and Hodgson et al.’s
systematic reviews. In conclusion of this meta-analysis, it demonstrates that while 3D breast
tomosynthesis does provide optimal results and better detection of breast cancer, it is not yet
found to be enough to replace 2D digital mammography. Rather, the two studies should be
combined and integrated into a routine screening protocol (Yun et al., 2017). This meta-analysis
demonstrates results from 11 eligible studies to conclude that risk ratios showed an increase in
cancer detection for 3D breast tomosynthesis plus 2D digital mammography than 2D digital
mammography alone for invasive cancer (1.327; 95% CI, 1.168-1.508), stage T1 (1.388; 95%
CI, 1.137-1.695), nodal-negative (1.451; 95% CI, 1.209-1.742), all histologic grades (grade I,
1.812; grade II/III, 1.403), and histologic types of invasive cancer (ductal, 1.437; lobular, 1.901)
(Yun et al., 2017). Combining 3D breast tomosynthesis with 2D digital mammography did not
increase detection of carcinoma in situ or nodal-positive cancer (Yun et al., 2017). Still, with the
increase in detection of other cancers and decrease in recall rates, 3D breast tomosynthesis
combined with 2D digital mammography offers a more reliable screening protocol for breast
cancer.
A randomized control trial was conducted by Pattacini et al. (2018). This involved 9,777
women ages 45-70 years old. Each woman was randomly assigned to undergo either 2D digital
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mammography combined with 3D breast tomosynthesis or 2D digital mammography alone. The
detection rate was about 90% higher with 3D breast tomosynthesis combined with 2D digital
mammography than with 2D digital mammography alone. The recall rate was 3.5% in both arms
(Pattacini et al., 2018).
Comparison of radiation doses between 2D digital mammography alone, 3D breast
tomosynthesis alone, and 2D digital mammography combined with 3D breast
tomosynthesis
Gennaro et al. (2017) published a per-view analysis comparing the radiation doses
between 3D breast tomosynthesis and 2D digital mammography. The analysis included 4,780 2D
digital mammography studies and 4,798 3D breast tomosynthesis studies from a total of 1,208
women. All in all, it found that there is a modest increase in dose for 3D breast tomosynthesis
(Gennaro et al., 2017). The estimated mean glandular dose (per view) was 1.36mGy (SD 0.51)
for 2D digital mammography, 1.87mGy (SD 0.67) from 3D breast tomosynthesis, and 3.22mGy
(SD 1.16) from combining the two imaging methods (Gennaro et al., 2017).
The ACR has a criterion mentioned earlier created by Mainiero et al. (2017) which also
states the increase in dose is either the same or a modest increase depending on the imaging
system being used (Mainiero et al., 2017). The randomized controlled study conducted by Aase
et al. (2018) reported that the mean glandular dose for 3D digital breast tomosynthesis was
2.96mGy and 2.95 for 2D digital mammography (p = 0.433) (Aase et al., 2018). Physicists work
with the imaging systems purchased by a health care facility in order to calibrate them
appropriately. The key is to deliver the lowest dose of radiation possible while maintaining
diagnostic quality of the images. Some imaging systems offer both 2D digital mammography and
3D breast tomosynthesis with little to no increase in radiation dose to the patient. This is
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significant when integrating 2D digital mammography and 3D breast tomosynthesis because
often patients assume the radiation dose is doubled.
Discussion
In women age 40 and older, does screening for breast cancer using 3D breast
tomosynthesis alone versus 2D digital mammography alone offer increased accuracy, specificity,
sensitivity, and less call back tests for patients?
3D breast tomosynthesis has the ability to digitally reconstruct the images provided by
2D digital mammography. Due to this advance in technology, it has been studied whether 3D
breast tomosynthesis could potentially replace 2D digital mammography. According to a metaanalysis included in this study, 3D breast tomosynthesis has not yet been found to be reliable
enough to replace 2D digital mammography and rather they should be combined and integrated
(Yun et al., 2017).
Mall et al. (2018) reported that 3D breast tomosynthesis demonstrates increased
sensitivity, specificity, positive predictive value, and negative predictive value when compared to
2D digital mammography. It also included that radiologists had improved performance when
reading 3D breast tomosynthesis compared to 2D digital mammography. In conclusion of the
study conducted by Mall et al. (2018), 3D breast tomosynthesis is superior to 2D digital
mammography and reduces the need for additional views which increases the patient’s radiation
exposure.
3D breast tomosynthesis increased and improved cancer detection rates and reduced
recall rates for false-positives in a study conducted by Mainiero et al. (2017). As discussed in the
introduction, the compression a woman endures for 2D digital mammography is the same
compression needed to obtain 3D breast tomosynthesis but slightly increased in amount of time.
The only harm to the patient is the risk of increased radiation dose when comparing 2D digital
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mammography to 3D breast tomosynthesis. According to Gennaro et al. (2017) and Mainiero et
al. (2018), there is only a modest increase in radiation dose when replacing 2D digital
mammography with 3D breast tomosynthesis. The randomized controlled study conducted by
Aase et al. (2018) demonstrated a 0.01mGy increase in radiation dose with 3D breast
tomosynthesis compared to 2D digital mammography. Gennaro et al. (2017) reported an increase
dose of 0.51mGy with 3D breast tomosynthesis. It is important to mention that the radiation dose
is different for each imaging system used. The radiation dose also depends on how the machine
is calibrated by the facility’s physicists.
In women age 40 and older, does screening for breast cancer using combination of 2D
digital mammography with 3D breast tomosynthesis versus 2D digital mammography alone or
3D breast tomosynthesis alone offer increased accuracy, specificity, sensitivity, and less call
back tests for patients?
When 3D breast tomosynthesis is combine with 2D digital mammography instead of
digitally constructing the views obtained by 2D digital mammography, this results in higher
invasive cancer detection rates and increased effectiveness of breast cancer screening making it
the superior screening protocol (Hodgson et al., 2016).
As stated previously, the study conducted by Yun et al. (2017) suggests that 3D breast
tomosynthesis is not yet proven to be diagnostically equivalent to 2D digital mammography
therefore it cannot replace it. Rather, these two modalities should be combined for optimal
screening of breast cancer. When 3D breast tomosynthesis is combine with 2D digital
mammography, cancer detection rate is 90% higher and most imaging vendors have developed
machines in which the dose of combining 3D and 2D is only slightly increased when compared
to 3D breast tomosynthesis alone (Pattacini et al., 2018). The study conducted by Pattacini et al.
(2018) does state in conclusion that the recall rates were not significantly different when
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comparing 3D breast tomosynthesis combined with 2D digital mammography versus 2D digital
mammography alone.
Overall, the review of the literature demonstrates that the combination of 3D breast
tomosynthesis and 2D digital mammography provides the most accurate detection of breast
cancer and the highest specificity, sensitivity, positive predictive value, negative predictive
value, and the lowest recall rate for further imaging. The only risk and negative side to this
combination being standard screening, is a modest increase in radiation dose and a slight increase
in time that the patient is under compression.
Applicability to Clinical Practice
When screening for breast cancer in women age 40 and up, the information provided in
this literature review assesses the most accurate tests available to patients. Traditionally,
screening for breast cancer involved 2 views of each breast using a 2D digital mammography
system. As health care facilities gain access to new types of technology and imaging systems, 3D
breast tomosynthesis is commonly combined with 2D digital mammography as part of the
screening protocol for breast cancer. Although adding the tomosynthesis view onto the 2D digital
mammography series slightly increases reading time by radiologists, radiologists have reported
that it is worth the increased reading time due to the increased specificity and sensitivity on the
patient’s test results.
When 3D breast tomosynthesis is combined with 2D digital mammography, the rate of
patients who got called back for further imaging were lower than the rate compared to 2D digital
mammography alone and 3D breast tomosynthesis alone. The greatest benefit of 3D breast
tomosynthesis is the technology it uses to look at tissue in the breast without superimposition.
This increase in specificity and sensitivity saves the patient from unnecessary anxiety, time taken
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out of their daily lives, and increased cost to the patient and facility. There have been instances
where 3D breast tomosynthesis has saved a patient from addition procedures that, in some cases,
can be invasive. This is especially important and significant in women with dense breast tissue.
Cancer hides easily in dense breast tissue on 2D digital mammography.
Some studies reported a slight increase in radiation dose when combining 3D breast
tomosynthesis with 2D digital mammography while other studies did not report an increase in
radiation. The radiation dose depends on the imaging system and the physicists who work
together to calibrate the system in order to deliver a radiation dose as low as reasonably
achievable. There are some imaging systems in which there is no increase in radiation dose when
3D breast tomosynthesis is combined with 2D digital mammography. This information is
incredibly valuable to providers when ordering screening mammography studies for women.
When a patient expresses concern about the added radiation or added compression they will
undergo, the information included in this literature review helps to better explain the
mammographic study including the risks and benefits.
If a health care facility’s protocol for breast cancer screening involves 3D breast
tomosynthesis combined with 2D digital mammography, it is proven in this literature review that
this offers the most accurate and safest imaging option for breast cancer screening in women 40
and older.
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